Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruijun Zhao

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Cancer|July 15, 2024
A Novel Signature Based on Angiogenesis-Related Genes Predicts the Prognosis and Immunotherapy Response in HER2-Positive Breast CancerShuanglong Chen, Weiheng Cui, Jiale Dong, et al.
Journal of Theoretical Biology|August 27, 2014
Quantifying the impact of decay in bed-net efficacy on malaria transmissionCalistus N Ngonghala, Sara Y Del Valle, Ruijun Zhao, et al.
The Journal of Physical Chemistry. B|March 28, 2012
αC helix as a switch in the conformational transition of Src/CDK-like kinase domainsHe Huang, Ruijun Zhao, Bradley M Dickson, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 26, 2021
Supersoft Elastic Bottlebrush Microspheres with Stimuli-Responsive Color-Changing Properties in BrineXiaotong Li, Bangbang Wang, Qiu-Jun Liu, et al.
Journal of Oncology|December 5, 2022
A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast CancerRuijun Zhao, Chaoyu Xie, Yu Gong, et al.
Frontiers in Immunology|November 8, 2023
PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancerRuijun Zhao, Shuanglong Chen, Weiheng Cui, et al.
International Journal of Biological Sciences|March 26, 2021
The G1 phase optical reporter serves as a sensor of CDK4/6 inhibition <i>in vivo</i>Cuiping Guo, Yuxian Guo, Jingjing Liu, et al.
International Immunopharmacology|March 26, 2013
Identification of oligomer proanthocyanidins (F2) isolated from grape seeds as a formyl peptide receptor 1 partial agonistJingyu Yang, Qing Wang, Ruijun Zhao, et al.
Cancer Cell International|December 16, 2025
Phosphorylated NCOA6 promotes aggressiveness and contributes patient outcomes in estrogen receptor-positive breast cancerHongmei Dong, Ruijun Zhao, Weiheng Cui, et al.
Frontiers in Immunology|August 25, 2022
PTPRO-related CD8<sup>+</sup> T-cell signatures predict prognosis and immunotherapy response in patients with breast cancerHongmei Dong, Chaoyu Xie, Zhimeng Yao, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Cancer|July 15, 2024
A Novel Signature Based on Angiogenesis-Related Genes Predicts the Prognosis and Immunotherapy Response in HER2-Positive Breast CancerShuanglong Chen, Weiheng Cui, Jiale Dong, et al.
Journal of Theoretical Biology|August 27, 2014
Quantifying the impact of decay in bed-net efficacy on malaria transmissionCalistus N Ngonghala, Sara Y Del Valle, Ruijun Zhao, et al.
The Journal of Physical Chemistry. B|March 28, 2012
αC helix as a switch in the conformational transition of Src/CDK-like kinase domainsHe Huang, Ruijun Zhao, Bradley M Dickson, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 26, 2021
Supersoft Elastic Bottlebrush Microspheres with Stimuli-Responsive Color-Changing Properties in BrineXiaotong Li, Bangbang Wang, Qiu-Jun Liu, et al.
Journal of Oncology|December 5, 2022
A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast CancerRuijun Zhao, Chaoyu Xie, Yu Gong, et al.
Frontiers in Immunology|November 8, 2023
PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancerRuijun Zhao, Shuanglong Chen, Weiheng Cui, et al.
International Journal of Biological Sciences|March 26, 2021
The G1 phase optical reporter serves as a sensor of CDK4/6 inhibition <i>in vivo</i>Cuiping Guo, Yuxian Guo, Jingjing Liu, et al.
International Immunopharmacology|March 26, 2013
Identification of oligomer proanthocyanidins (F2) isolated from grape seeds as a formyl peptide receptor 1 partial agonistJingyu Yang, Qing Wang, Ruijun Zhao, et al.
Cancer Cell International|December 16, 2025
Phosphorylated NCOA6 promotes aggressiveness and contributes patient outcomes in estrogen receptor-positive breast cancerHongmei Dong, Ruijun Zhao, Weiheng Cui, et al.
Frontiers in Immunology|August 25, 2022
PTPRO-related CD8<sup>+</sup> T-cell signatures predict prognosis and immunotherapy response in patients with breast cancerHongmei Dong, Chaoyu Xie, Zhimeng Yao, et al.
Pageof 3